APO Research
Talk to an analyst

APO RESEARCH · REPORT

Multivalent Oral Rotavirus Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Research

Multivalent Oral Rotavirus Vaccine Industry Research Report 2026

28 December 2025112 pages

Choose your research edition.

Industry ResearchMultivalent Oral Rotavirus Vaccine Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Multivalent Oral Rotavirus Vaccine Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Multivalent Oral Rotavirus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Multivalent Oral Rotavirus Vaccine Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Multivalent Oral Rotavirus Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Multivalent Oral Rotavirus Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Multivalent Oral Rotavirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Multivalent Oral Rotavirus Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Multivalent Oral Rotavirus Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Multivalent Oral Rotavirus Vaccine include Serum Institute of India, Lanzhou Institute of Biological Products and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Multivalent Oral Rotavirus Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Multivalent Oral Rotavirus Vaccine Market by Company

Serum Institute of India

Lanzhou Institute of Biological Products

Merck

Multivalent Oral Rotavirus Vaccine Segment by Type

RV3

RV5

Multivalent Oral Rotavirus Vaccine Segment by Application

Government Institution

Private Sector

Other

Multivalent Oral Rotavirus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multivalent Oral Rotavirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Multivalent Oral Rotavirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multivalent Oral Rotavirus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Multivalent Oral Rotavirus Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Multivalent Oral Rotavirus Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Multivalent Oral Rotavirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Multivalent Oral Rotavirus Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Multivalent Oral Rotavirus Vaccine Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Multivalent Oral Rotavirus Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global Multivalent Oral Rotavirus Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Multivalent Oral Rotavirus Vaccine Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Multivalent Oral Rotavirus Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Multivalent Oral Rotavirus Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Multivalent Oral Rotavirus Vaccine, Product Type & Application Table 14. Global Multivalent Oral Rotavirus Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Multivalent Oral Rotavirus Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Serum Institute of India Company Information Table 19. Serum Institute of India Business Overview Table 20. Serum Institute of India Multivalent Oral Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Serum Institute of India Multivalent Oral Rotavirus Vaccine Product Portfolio Table 22. Serum Institute of India Recent Developments Table 23. Lanzhou Institute of Biological Products Company Information Table 24. Lanzhou Institute of Biological Products Business Overview Table 25. Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Product Portfolio Table 27. Lanzhou Institute of Biological Products Recent Developments Table 28. Merck Company Information Table 29. Merck Business Overview Table 30. Merck Multivalent Oral Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Merck Multivalent Oral Rotavirus Vaccine Product Portfolio Table 32. Merck Recent Developments Table 33. Global Multivalent Oral Rotavirus Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 34. Global Multivalent Oral Rotavirus Vaccine Sales by Region (2021-2026) & (K Units) Table 35. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Region (2021-2026) Table 36. Global Multivalent Oral Rotavirus Vaccine Sales by Region (2027-2032) & (K Units) Table 37. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Region (2027-2032) Table 38. Global Multivalent Oral Rotavirus Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 39. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Region (2021-2026) Table 40. Global Multivalent Oral Rotavirus Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 41. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Region (2027-2032) Table 42. North America Multivalent Oral Rotavirus Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. North America Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 44. North America Multivalent Oral Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 45. North America Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 46. North America Multivalent Oral Rotavirus Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 47. Europe Multivalent Oral Rotavirus Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Europe Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 49. Europe Multivalent Oral Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 50. Europe Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 51. Europe Multivalent Oral Rotavirus Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 52. Asia Pacific Multivalent Oral Rotavirus Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Asia Pacific Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Multivalent Oral Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 56. Asia Pacific Multivalent Oral Rotavirus Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 57. South America Multivalent Oral Rotavirus Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. South America Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 59. South America Multivalent Oral Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 60. South America Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 61. South America Multivalent Oral Rotavirus Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 62. Middle East and Africa Multivalent Oral Rotavirus Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Middle East and Africa Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2026) & (K Units) Table 64. Middle East and Africa Multivalent Oral Rotavirus Vaccine Sales by Country (2027-2032) & (K Units) Table 65. Middle East and Africa Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 66. Middle East and Africa Multivalent Oral Rotavirus Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 67. Global Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2026) & (K Units) Table 68. Global Multivalent Oral Rotavirus Vaccine Sales by Type (2027-2032) & (K Units) Table 69. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2026) Table 70. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2027-2032) Table 71. Global Multivalent Oral Rotavirus Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 72. Global Multivalent Oral Rotavirus Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 73. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Type (2021-2026) Table 74. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Type (2027-2032) Table 75. Global Multivalent Oral Rotavirus Vaccine Price by Type (2021-2026) & (US$/Unit) Table 76. Global Multivalent Oral Rotavirus Vaccine Price by Type (2027-2032) & (US$/Unit) Table 77. Global Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2026) & (K Units) Table 78. Global Multivalent Oral Rotavirus Vaccine Sales by Application (2027-2032) & (K Units) Table 79. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2021-2026) Table 80. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2027-2032) Table 81. Global Multivalent Oral Rotavirus Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 82. Global Multivalent Oral Rotavirus Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 83. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Application (2021-2026) Table 84. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Application (2027-2032) Table 85. Global Multivalent Oral Rotavirus Vaccine Price by Application (2021-2026) & (US$/Unit) Table 86. Global Multivalent Oral Rotavirus Vaccine Price by Application (2027-2032) & (US$/Unit) Table 87. Key Raw Materials Table 88. Raw Materials Key Suppliers Table 89. Multivalent Oral Rotavirus Vaccine Distributors List Table 90. Multivalent Oral Rotavirus Vaccine Customers List Table 91. Multivalent Oral Rotavirus Vaccine Industry Trends Table 92. Multivalent Oral Rotavirus Vaccine Industry Drivers Table 93. Multivalent Oral Rotavirus Vaccine Industry Restraints Table 94. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Multivalent Oral Rotavirus Vaccine Product Image Figure 5. Global Multivalent Oral Rotavirus Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Multivalent Oral Rotavirus Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global Multivalent Oral Rotavirus Vaccine Sales (2021-2032) & (K Units) Figure 8. Global Multivalent Oral Rotavirus Vaccine Average Price (US$/Unit) & (2021-2032) Figure 9. RV3 Product Image Figure 10. RV5 Product Image Figure 11. Government Institution Product Image Figure 12. Private Sector Product Image Figure 13. Other Product Image Figure 14. Global Multivalent Oral Rotavirus Vaccine Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Multivalent Oral Rotavirus Vaccine, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Multivalent Oral Rotavirus Vaccine Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Multivalent Oral Rotavirus Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Multivalent Oral Rotavirus Vaccine Sales by Region in 2025 Figure 20. Global Multivalent Oral Rotavirus Vaccine Revenue by Region in 2025 Figure 21. North America Multivalent Oral Rotavirus Vaccine Market Size by Country in 2025 Figure 22. North America Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021-2032) Figure 23. North America Multivalent Oral Rotavirus Vaccine Revenue Market Share by Country (2021-2032) Figure 24. United States Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Multivalent Oral Rotavirus Vaccine Market Size by Country in 2025 Figure 28. Europe Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021-2032) Figure 29. Europe Multivalent Oral Rotavirus Vaccine Revenue Market Share by Country (2021-2032) Figure 30. Germany Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Multivalent Oral Rotavirus Vaccine Market Size by Country in 2025 Figure 41. Asia Pacific Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Multivalent Oral Rotavirus Vaccine Revenue Market Share by Country (2021-2032) Figure 43. China Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Multivalent Oral Rotavirus Vaccine Market Size by Country in 2025 Figure 52. South America Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021-2032) Figure 53. South America Multivalent Oral Rotavirus Vaccine Revenue Market Share by Country (2021-2032) Figure 54. Brazil Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Multivalent Oral Rotavirus Vaccine Market Size by Country in 2025 Figure 58. Middle East and Africa Multivalent Oral Rotavirus Vaccine Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Multivalent Oral Rotavirus Vaccine Revenue Market Share by Country (2021-2032) Figure 60. Egypt Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Multivalent Oral Rotavirus Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2032) Figure 66. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Type (2021-2032) Figure 67. Global Multivalent Oral Rotavirus Vaccine Price (US$/Unit) by Type (2021-2032) Figure 68. Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2021-2032) Figure 69. Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Application (2021-2032) Figure 70. Global Multivalent Oral Rotavirus Vaccine Price (US$/Unit) by Application (2021-2032) Figure 71. Multivalent Oral Rotavirus Vaccine Value Chain Figure 72. Multivalent Oral Rotavirus Vaccine Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Multivalent Oral Rotavirus Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • RV3
  • RV5
Applications
  • Government Institution
  • Private Sector
  • Other
Companies covered
  • Serum Institute of India
  • Lanzhou Institute of Biological Products
  • Merck

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Multivalent Oral Rotavirus Vaccine Market Size (2021-2032)
  4. 2.2.2 Global Multivalent Oral Rotavirus Vaccine Sales (2021-2032)
  5. 2.2.3 Global Multivalent Oral Rotavirus Vaccine Market Average Price (2021-2032)
  6. 2.3 Multivalent Oral Rotavirus Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 RV3
  9. 2.3.3 RV5
  10. 2.4 Multivalent Oral Rotavirus Vaccine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Government Institution
  13. 2.4.3 Private Sector
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Multivalent Oral Rotavirus Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Multivalent Oral Rotavirus Vaccine Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Multivalent Oral Rotavirus Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Multivalent Oral Rotavirus Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Multivalent Oral Rotavirus Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Multivalent Oral Rotavirus Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Multivalent Oral Rotavirus Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of Multivalent Oral Rotavirus Vaccine, Established Date
  9. 3.9 Global Multivalent Oral Rotavirus Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Serum Institute of India
  2. 4.1.1 Serum Institute of India Company Information
  3. 4.1.2 Serum Institute of India Business Overview
  4. 4.1.3 Serum Institute of India Multivalent Oral Rotavirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Serum Institute of India Multivalent Oral Rotavirus Vaccine Product Portfolio
  6. 4.1.5 Serum Institute of India Recent Developments
  7. 4.2 Lanzhou Institute of Biological Products
  8. 4.2.1 Lanzhou Institute of Biological Products Company Information
  9. 4.2.2 Lanzhou Institute of Biological Products Business Overview
  10. 4.2.3 Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Lanzhou Institute of Biological Products Multivalent Oral Rotavirus Vaccine Product Portfolio
  12. 4.2.5 Lanzhou Institute of Biological Products Recent Developments
  13. 4.3 Merck
  14. 4.3.1 Merck Company Information
  15. 4.3.2 Merck Business Overview
  16. 4.3.3 Merck Multivalent Oral Rotavirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Merck Multivalent Oral Rotavirus Vaccine Product Portfolio
  18. 4.3.5 Merck Recent Developments
5 Global Multivalent Oral Rotavirus Vaccine Market Scenario by Region
  1. 5.1 Global Multivalent Oral Rotavirus Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Multivalent Oral Rotavirus Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global Multivalent Oral Rotavirus Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global Multivalent Oral Rotavirus Vaccine Sales by Region: 2027-2032
  5. 5.3 Global Multivalent Oral Rotavirus Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global Multivalent Oral Rotavirus Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global Multivalent Oral Rotavirus Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America Multivalent Oral Rotavirus Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America Multivalent Oral Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Multivalent Oral Rotavirus Vaccine Market Facts & Figures by Country
  16. 5.5.1 Europe Multivalent Oral Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2032)
  18. 5.5.3 Europe Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Multivalent Oral Rotavirus Vaccine Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Multivalent Oral Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Multivalent Oral Rotavirus Vaccine Market Facts & Figures by Country
  41. 5.7.1 South America Multivalent Oral Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2032)
  43. 5.7.3 South America Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Multivalent Oral Rotavirus Vaccine Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Multivalent Oral Rotavirus Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Multivalent Oral Rotavirus Vaccine Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Multivalent Oral Rotavirus Vaccine Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Multivalent Oral Rotavirus Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global Multivalent Oral Rotavirus Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Multivalent Oral Rotavirus Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Multivalent Oral Rotavirus Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Multivalent Oral Rotavirus Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global Multivalent Oral Rotavirus Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Multivalent Oral Rotavirus Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Multivalent Oral Rotavirus Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Multivalent Oral Rotavirus Vaccine Value Chain Analysis
  2. 8.1.1 Multivalent Oral Rotavirus Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Multivalent Oral Rotavirus Vaccine Production Mode & Process
  5. 8.2 Multivalent Oral Rotavirus Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Multivalent Oral Rotavirus Vaccine Distributors
  8. 8.2.3 Multivalent Oral Rotavirus Vaccine Customers
9 Global Multivalent Oral Rotavirus Vaccine Analyzing Market Dynamics
  1. 9.1 Multivalent Oral Rotavirus Vaccine Industry Trends
  2. 9.2 Multivalent Oral Rotavirus Vaccine Industry Drivers
  3. 9.3 Multivalent Oral Rotavirus Vaccine Industry Opportunities and Challenges
  4. 9.4 Multivalent Oral Rotavirus Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst